Product Description
| Brand |
Beckman Coulter |
| Sample Type |
Serum/ Plasma |
| Pack Size |
2 x 50T |
| CAT No. |
A40702 |
Application
|
Torch Panel |
Beckman Coulter Access CMV IgG (CLIA) is a high-performance Chemiluminescent Immunoassay (CLIA) reagent designed for the qualitative determination of IgG antibodies to Cytomegalovirus (CMV) in human serum and plasma. CMV IgG antibody testing is widely used in prenatal screening, organ transplant programs, immunocompromised patient management, and infectious disease diagnostics. The Access CMV IgG CLIA Reagent delivers high sensitivity, excellent specificity, rapid turnaround time, and reliable results, making it an ideal choice for hospitals, diagnostic laboratories, pathology laboratories, blood banks, transplant centers, and reference laboratories.
Efficient CMV IgG Antibody DetectionThe BC Access CMV IgG (CLIA) offers laboratories a reliable and rapid solution for detecting Cytomegalovirus IgG antibodies. This analyzer leverages advanced chemiluminescence immunoassay (CLIA) technology, providing quick and accurate results that aid in screening and diagnosing CMV infections. Its automatic operation is tailored for seamless integration into any laboratory workflow, enhancing throughput and efficiency for medical professionals.
Portable and Real-Time OperationDesigned for portability, this CLIA analyzer is ideal for settings that require flexible laboratory equipment. Real-time operation means test results are available promptly, which is particularly beneficial for urgent clinical decision-making. The system's automatic functionality minimizes user intervention, reducing potential errors and ensuring consistent, precise data output for every analysis.
FAQ's of BC Access CMV IgG (CLIA):
Q: How does the BC Access CMV IgG (CLIA) analyzer determine CMV IgG antibodies?
A: The analyzer employs chemiluminescence immunoassay (CLIA) technology to detect and quantify IgG antibodies specific to Cytomegalovirus in patient samples, offering high sensitivity and reliable results.
Q: What are the main benefits of using an automatic, portable CLIA analyzer in laboratories?
A: Its automatic and portable design simplifies workflow, reduces operator error, and enables laboratories to conduct tests efficiently-whether in central or remote facilities-while ensuring prompt, accurate diagnosis.
Q: When should testing for CMV IgG antibodies be considered using this analyzer?
A: Testing is typically indicated when CMV infection is suspected, for prenatal screening, organ transplant compatibility, or in immunocompromised patients where monitoring CMV status is crucial.
Q: Where is the BC Access CMV IgG (CLIA) analyzer commonly used?
A: This analyzer is used in clinical laboratories, hospital diagnostic centers, and other healthcare environments throughout India, wherever CMV antibody detection aids patient care.
Q: What is the recommended storage condition for the BC Access CMV IgG (CLIA)?
A: To ensure device performance and longevity, the analyzer should be stored at a temperature range between 2 and 10 degrees Celsius.
Q: Can the analyzer provide results in real-time, and how does this impact laboratory workflows?
A: Yes, it delivers real-time results, helping laboratories expedite diagnosis and promote quicker clinical interventions, which is especially vital in time-sensitive cases.